Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Consumer Cyclical Healthcare Technology Advertising Agencies Biotechnology Software - Application Cannabis
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.


TSX:WLLW - Post by User

Willow Biosciences Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by witsguyon Dec 21, 2016 9:38pm
136 Views
Post# 25633127

RE:RE:Keep in mind

RE:RE:Keep in mind
starman1975 wrote:
radar17 wrote:
this is the same crew that reported,...  "During another phase of a work program the Company completed a 102 tonne bulk sample from which the average grade was 4 oz/t or 137.1 g/t gold over the 102 individually tested one tonne samples. (October 25, 2011)"

... but then decided not to do anything about it.  Who gets 137 g/t Au in a bulk sample then decides its not worth pursuing and swithces to uranium exploration?  If it looks like bullshite, smells like bullshite ....

Yes it was another company, I heard it was bre-x that gave them those numbers but they are gone.  17 g/t is great for a company that is frugal on r&d.  it lets others do all the work then reap the rewards. 


Haha frugal on "r and D"? Too funny whjat R and D does a "exploration" shell do? I hazard a guess of zero. how "frugal" is this shell with paying phone boys aka ""IR""?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities